Improvement in Hepatic Encephalopathy with Rifaximin Is Associated with Distinct Changes in the Metagenomic Species in the Saliva and Stool Microbiome and a Reduction in Systemic Inflammation - Results of the Rifsys Randomized Controlled Trial.

Vishal C. Patel, Mark J. McPhail, Ane Zamalloa, Sidsel Stoy, Godhev K. Manakkat Vijay, Elizabeth Witherden, Sunjae Lee, Saeed Shoaie, Xiaohong Huang, Geraint Rogers, Jocelyn Choo, Rabiya Zia, Lindsey Edwards, Elizabeth Gray, Charlotte A. Woodhouse, Selin Gencer, Muireann Cohen, Julia Wendon, Stanislav Dusko Erhlich, Kenneth BruceDebbie L. Shawcross

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)1462A-1463A
Issue number6
Publication statusPublished - Dec 2018

Cite this